Home-based Intervention to Test and Start
HITS
Home-based Interventions to Test and Start (HITS): a Cluster-randomized Controlled Trial to Reduce Mortality and Incidence Through HIV Treatment
1 other identifier
interventional
4,667
1 country
1
Brief Summary
This study aims to establish the causal impact of two interventions - micro-incentives and a male-sensitive HIV- specific decision support app - on population-level HIV viral load and HIV-related mortality in men, as well as on population-based HIV incidence in young women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hiv
Started Feb 2018
Longer than P75 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 6, 2018
CompletedFirst Submitted
Initial submission to the registry
October 31, 2018
CompletedFirst Posted
Study publicly available on registry
November 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedNovember 28, 2018
November 1, 2018
3.9 years
October 31, 2018
November 27, 2018
Conditions
Outcome Measures
Primary Outcomes (5)
HIV testing uptake at point of test offer in men
% received the rapid HIV test at home among those offered the test in men
Baseline
HIV treatment linkage at 1 year in men
% who visited study clinics and initiated antiretroviral therapy (ART) in men
year 1
Population-level HIV viral suppression in men
Change in proportion with detectable viremia in men; HIV testing and viral load measurements are performed on the dried blood spot (DBS) samples collected during the annual survey
year 1
Population-level HIV-related mortality in men
Change in HIV-related mortality rate measured as the number of HIV-related deaths per 1000 person-years of observation in men
year 3
Population-level HIV incidence in young women (15-30 years of age)
Change in HIV incidence rate (number of HIV sero-conversions per 100 person-years of follow up) in young women; HIV testing and viral load measurements are performed on the DBS samples collected during the annual survey
year 3
Secondary Outcomes (26)
HIV testing uptake at point of test offer in women
Baseline
HIV treatment linkage at 1 year in women
year 1
Population-level HIV viral suppression (both sexes)
year 1
Population-level HIV viral suppression (both sexes)
year 3
Population-level HIV viral suppression in women
year 1
- +21 more secondary outcomes
Study Arms (4)
micro-incentives
EXPERIMENTALmicro-incentives only (8 communities)
EPIC-HIV
EXPERIMENTALEmpowered through informed choice for HIV \[male sensitive HIV specific decision support app\] (males only in 8 communities)
micro-incentive and EPIC-HIV
EXPERIMENTALmicro-incentives as well as EPIC \[male sensitive HIV specific decision support app\] (8 communities)
control
NO INTERVENTIONstandard of care
Interventions
Residents in these communities are eligible to receive a R50 food voucher conditional on undergoing a home-based HIV test. If diagnosed with HIV, residents are eligible to receive a second R50 food voucher when they link to care within 6 weeks of the HIV test
Men in these communities are eligible to receive a tablet-based male-sensitive HIV decision support app (EPIC-HIV 1)to encourage them to test for HIV at home. If diagnosed with HIV and do not link to care within a month of HIV test, they become eligible to receive a tablet-based male HIV specific decision support app (EPIC-HIV 2) to encourage them to link to HIV care.
micro-incentives: Residents in these communities are eligible to receive a R50 food voucher conditional on undergoing a home-based HIV test. If diagnosed with HIV, residents are eligible to receive a second R50 food voucher when they link to care within 6 weeks of the HIV test. EPIC-HIV 1: Men in these communities are eligible to receive a tablet-based male-sensitive HIV specific decision support app (EPIC-HIV 1) to encourage them to test for HIV at home. If diagnosed with HIV and do not link to care within a month of HIV test, they become eligible to receive a tablet-based male HIV specific decision support app (EPIC-HIV 2) to encourage them to link to HIV care.
Eligibility Criteria
You may qualify if:
- years old and above
- Resident members of households within the Population Intervention Platform
- Have consented to participate in Population Intervention Platform
- additional eligibility criteria for EPIC-HIV
- Male
You may not qualify if:
- Refused to take part in Population Intervention Platform
- Participant reported to already be on ART
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Africa Health Research Institutelead
- Heidelberg Universitycollaborator
- University College, Londoncollaborator
- London School of Hygiene and Tropical Medicinecollaborator
- University of Glasgowcollaborator
- University of Southamptoncollaborator
Study Sites (1)
AHRI
Mtubatuba, KwaZulu-Natal, 3935, South Africa
Related Publications (5)
Kim HY, Inghels M, Mathenjwa T, Shahmanesh M, Seeley J, Matthews P, Wyke S, McGrath N, Adeagbo O, Gareta D, Yapa HM, Zuma T, Dobra A, Blandford A, Barnighausen T, Tanser F. Effect of a Male-Targeted Digital Decision Support Application Aimed at Increasing Linkage to HIV Care Among Men: Findings from the HITS Cluster Randomized Clinical Trial in Rural South Africa. AIDS Behav. 2025 Jan;29(1):1-12. doi: 10.1007/s10461-024-04465-1. Epub 2024 Sep 11.
PMID: 39259239DERIVEDKim HY, Inghels M, Mathenjwa T, Shahmanesh M, Seeley J, Matthews P, McGrath N, Adeagbo O, Gareta D, Yapa HM, Zuma T, Dobra A, Barnighausen T, Tanser F. The impact of a conditional financial incentive on linkage to HIV care: Findings from the HITS cluster randomized clinical trial in rural South Africa. medRxiv [Preprint]. 2024 Mar 18:2024.03.15.24304278. doi: 10.1101/2024.03.15.24304278.
PMID: 38562873DERIVEDKim HY, Inghels M, Mathenjwa T, Shahmanesh M, Seeley J, Matthews P, Wyke S, McGrath N, Adeagbo O, Gareta D, Yapa HM, Zuma T, Dobra A, Blandford A, Barnighausen T, Tanser F. Effect of a male-targeted digital decision support application aimed at increasing linkage to HIV care among men: Findings from the HITS cluster randomized clinical trial in rural South Africa. medRxiv [Preprint]. 2024 Mar 18:2024.03.15.24304373. doi: 10.1101/2024.03.15.24304373.
PMID: 38562824DERIVEDMakofane K, Kim HY, Tchetgen Tchetgen E, Bassett MT, Berkman L, Adeagbo O, McGrath N, Seeley J, Shahmanesh M, Yapa HM, Herbst K, Tanser F, Barnighausen T. Impact of family networks on uptake of health interventions: evidence from a community-randomized control trial aimed at increasing HIV testing in South Africa. J Int AIDS Soc. 2023 Aug;26(8):e26142. doi: 10.1002/jia2.26142.
PMID: 37598389DERIVEDTanser FC, Kim HY, Mathenjwa T, Shahmanesh M, Seeley J, Matthews P, Wyke S, McGrath N, Adeagbo O, Sartorius B, Yapa HM, Zuma T, Zeitlin A, Blandford A, Dobra A, Barnighausen T. Home-Based Intervention to Test and Start (HITS): a community-randomized controlled trial to increase HIV testing uptake among men in rural South Africa. J Int AIDS Soc. 2021 Feb;24(2):e25665. doi: 10.1002/jia2.25665.
PMID: 33586911DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Frank Tanser, PhD
Africa Health Research Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 31, 2018
First Posted
November 28, 2018
Study Start
February 6, 2018
Primary Completion
December 31, 2021
Study Completion
December 31, 2022
Last Updated
November 28, 2018
Record last verified: 2018-11